PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment
作者： Wing Lam , Zaoli Jiang , Fulan Guan , Xiu Huang , Rong Hu
DOI: 10.1038/SREP09384
关键词: Adjuvant 、 Sorafenib 、 Apoptosis 、 Scutellaria baicalensis 、 Cell growth 、 Tumor microenvironment 、 In vivo 、 Medicine 、 Pharmacology 、 Fas ligand
摘要: … enhance the therapeutic indices of different class anticancer agents in vivo. Here, PHY906 is reported to enhance the anti-tumor activity … hMCP1 expression and enhancing infiltration of …
nature.com
elsevier.com
harvard.edu
sci-hub.se 参考文章(33)
Sebastien Cagnol, Jean-Claude Chambard, ERK and cell death: Mechanisms of ERK‐induced cell death – apoptosis, autophagy and senescence FEBS Journal. ,vol. 277, pp. 2- 21 ,(2010) , 10.1111/J.1742-4658.2009.07366.X
M. Wasif Saif, Samuel So, Yun Yen, Tahmun Su, Zaoli Jiang, Shwu Huey Liu, Yung Chi Cheng, Edward Chu, Edward Chu, Angeline Foo, Michal Rose, Phase I/II study of PHY906/capecitabine in advanced hepatocellular carcinoma. Anticancer Research. ,vol. 29, pp. 4083- 4092 ,(2009)
Josep M. Llovet, Jordi Bruix, Molecular targeted therapies in hepatocellular carcinoma. Hepatology. ,vol. 48, pp. 1312- 1327 ,(2008) , 10.1002/HEP.22506
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857
Muhammad Wasif Saif, Jia Li, Lynne Lamb, Kristin Kaley, Kyle Elligers, Zaoli Jiang, Scott Bussom, Shwu-Huey Liu, Yung-Chi Cheng, First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer Cancer Chemotherapy and Pharmacology. ,vol. 73, pp. 373- 380 ,(2014) , 10.1007/S00280-013-2359-7
Eric Ogier-Denis, Sophie Pattingre, Jamel El Benna, Patrice Codogno, Erk1/2-dependent Phosphorylation of Gα-interacting Protein Stimulates Its GTPase Accelerating Activity and Autophagy in Human Colon Cancer Cells Journal of Biological Chemistry. ,vol. 275, pp. 39090- 39095 ,(2000) , 10.1074/JBC.M006198200
Hyun-Jung An, Oky Maeng, Kyoung-Hee Kang, Jie-Oh Lee, Young-Sang Kim, Sang-Gi Paik, Hayyoung Lee, Activation of Ras Up-regulates Pro-apoptotic BNIP3 in Nitric Oxide-induced Cell Death Journal of Biological Chemistry. ,vol. 281, pp. 33939- 33948 ,(2006) , 10.1074/JBC.M605819200
Yan Cheng, Feng Qiu, Shin-ichi Tashiro, Satoshi Onodera, Takashi Ikejima, ERK and JNK mediate TNFα-induced p53 activation in apoptotic and autophagic L929 cell death Biochemical and Biophysical Research Communications. ,vol. 376, pp. 483- 488 ,(2008) , 10.1016/J.BBRC.2008.09.018
Michael P. Farrell, Shivaani Kummar, Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer. Clinical Colorectal Cancer. ,vol. 2, pp. 253- 256 ,(2003) , 10.3816/CCC.2003.N.007
Wei Zhang, Muhammad W. Saif, Ginger E. Dutschman, Xin Li, Wing Lam, Scott Bussom, Zaoli Jiang, Min Ye, Edward Chu, Yung-Chi Cheng, Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Journal of Chromatography A. ,vol. 1217, pp. 5785- 5793 ,(2010) , 10.1016/J.CHROMA.2010.07.045